Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CYTK
Stock Latest News
Company Announcements
Cytokinetics Appoints James M. Daly to Board
4d ago
8K
CYTK
Premium
The Fly
Rezolute appoints Karnawat as Chief Commercial Officer
4d ago
CYTK
RARE
Premium
The Fly
Cytokinetics names Jim Daly to Board of Directors
4d ago
CYTK
INCY
Premium
Company Announcements
Cytokinetics’ Aficamten Study: A Potential Breakthrough for Pediatric Heart Health
9d ago
CYTK
Premium
Ratings
Cytokinetics: Promising Outlook with Aficamten’s Regulatory Progress and Strong Financial Health
12d ago
CYTK
Premium
Company Announcements
Cytokinetics’ Earnings Call: Progress Amid Challenges
12d ago
CYTK
Premium
Ratings
Buy Rating for Cytokinetics Driven by Regulatory Reviews and Strategic Trials for Drug Afi
15d ago
CYTK
Premium
The Fly
Cytokinetics price target lowered to $77 from $80 at Citi
16d ago
CYTK
Premium
Ratings
Cytokinetics Positioned for Success: Strong Financials and Strategic Advancements Drive Buy Rating
16d ago
CYTK
Premium
Company Announcements
Cytokinetics Reports Q2 2025 Financial Results and Updates
16d ago
CYTK
Premium
Pre-Earnings
CYTK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
CYTK
Premium
Ratings
Cytokinetics’ Strong Market Position and Growth Potential Justify Buy Rating
23d ago
CYTK
Premium
The Fly
Cytokinetics assumed with Market Perform from Outperform at Raymond James
25d ago
CYTK
Premium
Company Announcements
Cytokinetics’ Aficamten Study: A New Hope for Pediatric Heart Patients
1M ago
CYTK
Premium
Company Announcements
Cytokinetics Advances Pediatric Heart Treatment with Aficamten Study
1M ago
CYTK
Premium
The Fly
Cytokinetics price target lowered to $53 from $71 at JPMorgan
3M ago
CYTK
Premium
Ratings
Promising Potential of Aficamten in Hypertrophic Cardiomyopathy Drives Buy Rating for Cytokinetics
3M ago
CYTK
Premium
The Fly
Cytokinetics price target lowered to $84 from $103 at Mizuho
3M ago
CYTK
Premium
Ratings
Promising SEQUOIA-HCM Study Data Justifies Buy Rating for Cytokinetics
3M ago
CYTK
Premium
The Fly
Cytokinetics presents additional data related to Aficamten
3M ago
CYTK
Premium
Company Announcements
Cytokinetics Announces Key Decisions at Annual Meeting
3M ago
8K
CYTK
Premium
The Fly
Cytokinetics to host symposium on Contemporary Landscapes in Muscle Biology
3M ago
CYTK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
